Europe Circulating Tumor Cell (CTC) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CTC Detection and Enrichment Method, CTC Direct Detection Method, and CTC Analysis), Application (Clinical/Liquid Biopsy, and Research), and End-User (Hospitals and Clinics, Research and Academic Institutes, and Diagnostic Centers)

Code: TIPRE00028647 | Pages: 139 | Industry: Medical Device | Date: Apr 2022 | Type: Regional

The Europe circulating tumor cell (CTC) diagnostics market is expected to reach US$ 957.8 million by 2028 from US$ 508.0 million in 2021; it is estimated to grow at a CAGR of 9.5% from 2021 to 2028.

 

Due to advancements in technologies related to feasibility and processing times, circulating tumor cell diagnostics and liquid biopsy have recently gathered considerable interest as a noninvasive alternative to tissue biopsy in cancer patients. The implementation of liquid biopsy procedures is supported by a greater understanding of improved minimally invasive cancer detection technologies. The market growth will be influenced by the rising demand for noninvasive tools, and laboratory acceptance of CTCs tests and liquid biopsy. A liquid biopsy allows doctors to obtain information about tumors from a simple blood sample. A blood test is painless, noninvasive, cost-effective, and less time-consuming. In addition, CTCs, cfDNAs, exosomes, and microvesicles can be detected in a blood sample, making blood-based liquid biopsies more popular.

 

The COVID-19 emergency has encouraged the general population to try out digital services and scale up their usage, particularly to avoid having to visit a health center in person. The unprecedented impact of COVID-19 has been far-reaching, but the effects on cancer patients make them one of the worst affected groups. COVID-19 has profoundly impacted the number of patients undergoing cancer screening, diagnosis, and treatment. The increased pressure due to the growing rate of COVID-19 patients' hospitalization led to the re-profiling of many hospitals and departments, including oncology clinics, for accommodating the increasingly large number of COVID-19 patients. According to one study, many diagnostic and treatment procedures, including 2.3 million cancer surgeries, were canceled or postponed worldwide. Thus, the pandemic hindered the circulating tumor cell (CTC) diagnostics market growth.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the circulating tumor cell (CTC) diagnostics market. The Europe circulating tumor cell (CTC) diagnostics market is expected to grow at a good CAGR during the forecast period.

 

Europe Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Europe Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Get more information on this report :


 

 

Europe Circulating Tumor Cell (CTC) Diagnostics Market Segmentation         

 By Technology

  • CTC detection and Enrichment Method
  • CTC Direct Detection Methods
  • CTC Analysis

 

By Application

  • Clinical/Liquid Biopsy
    • Risk Assessment
    • Screening and Monitoring
  • Research
    • Cancer Stem Cell and Tumorigenesis Research
    • Drug/Therapy Development

 

By End-User

  • Hospitals and Clinics
  • Research and Academic Institutes
  • Diagnostic Centers

 

By Country

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

 

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Stemcell Technologies Inc.
  • Qiagen
  • Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  • Screencell
  • Ikonisys, Inc
  • Fluxion Biosciences
 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Circulating Tumor Cell (CTC) Diagnostics Market – By Technology

1.3.2        Europe Circulating Tumor Cell (CTC) Diagnostics Market – By Application

1.3.3        Europe Circulating Tumor Cell (CTC) Diagnostics Market – By End-User

1.3.4        Europe Circulating Tumor Cell (CTC) Diagnostics Market – By Geography

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Circulating Tumor Cell (CTC) Diagnostics Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Europe PEST Analysis

4.3         Experts Opinion

5.           Circulating Tumor Cell (CTC) Diagnostics Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Prevalence of Cancer

5.1.2        Rising Demand for Minimally Invasive Diagnostic Procedures

5.2         Market Restraints

5.2.1        Dearth of Skilled Professionals Performing Diagnostic Procedures

5.3         Market Opportunities

5.3.1        Untapped Potential of Emerging Economies

5.4         Future Trends

5.4.1        Technological Advancements in Isolation of Circulating Tumor Cell

5.5         Impact Analysis

6.           Circulating Tumor Cell (CTC) Diagnostics Market– Europe Analysis

6.1         Europe Circulating Tumor Cell (CTC) Diagnostics Market Revenue Forecast and Analysis

7.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Technology

7.1         Overview

7.2         Europe Circulating Tumor Cell (CTC) Diagnostics Market, By Technology, 2020 & 2028 (%)

7.3         CTC detection and Enrichment Method

7.3.1        Overview

7.3.2        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.4         CTC Direct Detection Method

7.4.1        Overview

7.4.2        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

7.5         CTC Analysis

7.5.1        Overview

7.5.2        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – Application

8.1         Overview

8.2         Europe Circulating Tumor Cell (CTC) Diagnostics Market Share, By Application - 2020 & 2028 (%)

8.3         Clinical/Liquid Biopsy

8.3.1        Overview

8.3.2        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.3        Risk Assessment

8.3.3.1          Overview

8.3.3.2          Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.3.4        Screening and Monitoring

8.3.4.1          Overview

8.3.4.2          Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4         Research

8.4.1        Overview

8.4.2        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.1          Cancer Stem Cell & Tumorigenesis Research

8.4.2.1.1          Overview

8.4.2.1.2          Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

8.4.2.2          Drug/Therapy Development

8.4.2.2.1          Overview

8.4.2.2.2          Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.           Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 – End user

9.1         Overview

9.2         Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

9.3         Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.4         Research and Academic Institutes

9.4.1        Overview

9.4.2        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

9.5         Diagnostic Centers

9.5.1        Overview

9.5.2        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

10.        Europe Circulating Tumor Cell (CTC) Diagnostics Market – Geographic Analysis

10.1      Europe: Circulating Tumor Cell (CTC) Diagnostics Market

10.1.1     Overview

10.1.2     Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.3     Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.4     Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.4.1       Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.4.2       Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)

10.1.5     Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

10.1.6     Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

10.1.6.1       Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.1       Overview

10.1.6.1.2       Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.3       Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4       Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.1.4.1     Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.6.1.4.2     Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.1.5       Germany: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

10.1.6.2       France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.1       Overview

10.1.6.2.2       France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.3       France: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4       France: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.2.4.1     France: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

10.1.6.2.4.2     France: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application , 2019–2028 (US$ Million)

10.1.6.2.5       France: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

10.1.6.3       UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.1       Overview

10.1.6.3.2       UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.3       UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4       UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.3.4.1     UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.6.3.4.2     UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.3.5       UK: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

10.1.6.4       Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.1       Overview

10.1.6.4.2       Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.3       Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.4       Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.4.4.1     Italy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Research Application (US$ Million)

10.1.6.4.4.2     Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.4.5       Italy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

10.1.6.5       Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.1       Overview

10.1.6.5.2       Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.3       Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.4       Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.5.4.1     Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.6.5.4.2     Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.5.5       Spain: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

10.1.6.6       Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.1       Overview

10.1.6.6.2       Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.3       Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.4       Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

10.1.6.6.4.1     Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application, 2019–2028 (US$ Million)

10.1.6.6.4.2     Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Clinical/ Liquid Biopsy Application, 2019–2028 (US$ Million)

10.1.6.6.5       Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

11.        Impact of COVID-19 Pandemic on Europe Circulating Tumor Cell (CTC) Diagnostics Market

11.1      Europe: Impact Assessment of COVID-19 Pandemic

12.        Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      THERMO FISHER SCIENTIFIC INC.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      STEMCELL Technologies Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      QIAGEN

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      ADVANCED CELL DIAGNOSTICS, INC. (BIO-TECHNE CORPORATION)

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      SCREENCELL

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      IKONISYS, INC.

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      FLUXION BIOSCIENCES

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 


LIST OF TABLES

Table 1.             Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 2.             Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 3.             Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 4.             Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 5.             Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 6.             Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 8.             Germany: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Germany: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 10.          Germany: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 11.          France: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12.          France: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 13.          France: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 14.          France: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 15.          France: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 16.          UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 17.          UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 18.          UK: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 19.          UK: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 20.          UK: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 21.          Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 23.          Italy: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Italy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 25.          Italy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 26.          Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 28.          Spain: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Spain: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 30.          Spain: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 31.          Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Application– Revenue and Forecast to 2028 (US$ Million)

Table 33.          Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Research Application – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028, by Clinical/ Liquid Biopsy Application (US$ Million)

Table 35.          Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 , by End User (US$ Million)

Table 36.          Organic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 37.          Inorganic Developments in the Circulating Tumor Cell (CTC) Diagnostics Market

Table 38.          Glossary of Terms, Circulating Tumor Cell (CTC) Diagnostics Market

 


LIST OF FIGURES

Figure 1.           Circulating Tumor Cell (CTC) Diagnostics Market Segmentation

Figure 2.           Europe Circulating Tumor Cell (CTC) Diagnostics Market Overview

Figure 3.           CTC detection and Enrichment Method Held Largest Share of Technology Segment in Circulating Tumor Cell (CTC) Diagnostics Market

Figure 4.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Europe Circulating Tumor Cell (CTC) Diagnostics Market, Industry Landscape

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Europe Circulating Tumor Cell (CTC) Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028

Figure 9.           Europe Circulating Tumor Cell (CTC) Diagnostics Market, by Technology, 2020 & 2028 (%)

Figure 10.        CTC Detection and Enrichment Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 11.        CTC Direct Detection Method: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 12.        CTC Analysis: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Europe Circulating Tumor Cell (CTC) Diagnostics Market Share, by Application - 2020 & 2028 (%)

Figure 14.        Clinical/Liquid Biopsy: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Risk Assessment: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Screening and Monitoring: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Cancer Stem Cell & Tumorigenesis Research: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Drug/Therapy Development: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Europe Circulating Tumor Cell (CTC) Diagnostics Market Share by End user - 2020 & 2028 (%)

Figure 21.        Hospitals and Clinics: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Research and Academic Institutes: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Diagnostic Centers: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

Figure 25.        Europe: Circulating Tumor Cell (CTC) Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Europe: Circulating Tumor Cell (CTC) Diagnostics Market, by Country, 2021 & 2028 (%)

Figure 27.        Germany: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        France: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        UK: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30.        Italy: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Spain: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        Rest of Europe: Circulating Tumor Cell (CTC) Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 33.        Impact of COVID-19 Pandemic in European Country Markets

Figure 34.        Growth Strategies in the Circulating Tumor Cell (CTC) Diagnostics Market (%)

  1. Thermo Fisher Scientific Inc.
  2. Stemcell Technologies Inc.
  3. Qiagen
  4. Advanced Cell Diagnostics, Inc. (Bio-Techne Corporation)
  5. Screencell
  6. Ikonisys, Inc
  7. Fluxion Biosciences
  8.  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000